Gene By Gene Rejects BRCA1/2 Patent Infringement Claims by Myriad and Joins Ambry Genetics to Sue Myriad for Violating Federal Antitrust Laws
Will continue to offer fast, accurate, and affordable alternative for BRCA1/2 testing
HOUSTON, Aug. 15, 2013 /PRNewswire/ -- Gene By Gene, Ltd. announced that it is teaming with Ambry Genetics to defend against Myriad Genetics' patent infringement lawsuits against both companies in connection with the BRCA1/2 tests being offered by Gene By Gene and Ambry Genetics. Both companies are also countersuing Myriad for violations of the Federal Antitrust Act.
On June 13, 2013, immediately following the United States Supreme Court's 9-0 landmark decision against Myriad in "Association For Molecular Pathology v. Myriad Genetics," Gene By Gene announced its intention to offer fast, accurate and affordable BRCA1/2 testing to the public.
Gene by Gene Acquires Arpeggi, a StartUp Health- and GE-Backed Company, to Build World's Leading Genetic Testing and Genome Diagnostics Company
Merger will make DNA testing more accessible and affordable for consumers, researchers and healthcare providers.
Gene by Gene, Ltd., the world's first company to develop consumer DNA testing products for ancestry and genealogy applications, announced today the acquisition of Arpeggi, Inc., a StartUp Health- and GE-backed company that develops solutions for genome sequencing, data management and computational analysis.
The combined company will enable the acceleration of an innovative suite of more affordable genetics testing and diagnostics services available to consumers, researchers and healthcare providers.
"The acquisition of Arpeggi's technology and world-class team of data and technology experts will enable us to accelerate Gene by Gene's plan to make next-generation DNA sequencing and clinical genomics accessible and affordable to all," said Max Blankfeld, Managing Partner of Gene by Gene. "We are on a mission to transform healthcare by dramatically speeding up the process, and reducing the costs, of genetic tests, which today are often far too expensive for the average consumer."
Supreme Court Ruling Today Allows DNATraits to Offer Low Cost BRCA Breast and Ovarian Cancer Gene Testing in U.S.
In effort to increase access to potentially lifesaving BRCA1 and BRCA2 tests, DNATraits can now offer tests for $995, a fraction of the cost of similar tests prior to the court decision.
Thanks to today's U.S. Supreme Court decision opening the door to greater access to genetic medicine by American patients and their health care providers, testing for genes specifically linked to breast, ovarian and other cancers will now be more widely available and at a lower cost than ever before.
DNATraits, a division of Houston-based genomics and genetics testing company Gene By Gene, Ltd., announced today that it will offer testing for the BRCA1 and BRCA2 genes in the United States for $995. Prior to today's unanimous Supreme Court ruling, when exorbitant licensing fees kept DNATraits and others from offering BRCA gene tests in the United States, the cost for such tests was around $4,000.
Gene By Gene, Pioneering Personalized DNA Sequencing Contributes to Genetic Disease Research in Jewish Population
Can ethnocultural genetics predict an individual’s potential susceptibility to certain diseases? In some instances it can.
Because of their relative genetic homogeneity, Ashkenazi Jews are also more susceptible to roughly 20 to 30 genetic diseases than the general population, and many are carriers for at least one illness inherited diseases due to inherited genetic mutations and traits. According to the Philedelphia-based Victor Center for the Prevention of Jewish Genetic Diseases there are 19 preventable genetic diseases with a 1 in 4 carrier rate among Jews. ...
Gene By Gene Signs Agreement with MD Anderson Cancer Center
Houston-based Gene By Gene, Ltd., a genomics and genetics testing company, has announced the inking a new agreement with the University of Texas MD Anderson Cancer Center to become one of the Center’s affiliated clinical laboratories.
"We’re delighted to partner with Gene By Gene, with its long and pioneering history in the field of genomics,” comments Program Director, Peter Hu, Ph.D., with the MD Anderson School of Health Professions in a release. “Gene By Gene’s sequencing, next-generation sequencing and microarray laboratory will provide the top level of experience and training that we want all our molecular students to attain.”...
Family Tree DNA Unveils $39 DNA Test in Major Step Toward Universal Access by Individuals to their Own Genetic Data
The world's lowest cost genetic test offers an introduction to the insights and knowledge to be gained from personal genetic and genomic research.
HOUSTON, Feb. 20, 2013 /PRNewswire/ -- FamilyTreeDNA.com, the genetic genealogy arm of Gene By Gene, Ltd., is dramatically lowering the price of one of its basic Y-DNA tests to $39, making it the lowest-cost DNA test available on the market, in order to take a major step toward universal access by individuals to their personal genetic data.
By dropping the price of its basic Y-DNA test by 60 percent to $39, Family Tree DNA -- the world's largest processor of Y-DNA and full mitochondrial sequences -- is working to eliminate cost as a barrier to individuals introducing themselves to the insights and knowledge to be gained from personal genetic and genomic research.
Family Tree DNA pioneered the concept of direct-to-consumer testing in the field of genetic genealogy more than a decade ago, and has processed more than 5 million discrete tests for more than 700,000 individuals and organizations since it introduced its Y-DNA test in 2000...
Gene By Gene Launches DNA DTC
Offers highly reliable, cost effective DNA testing to institutional clients worldwide.
HOUSTON—Nov. 29, 2012 – The world’s largest processor of full mitochondria sequences, Gene By Gene, Ltd., today announced the launch of DNA DTC to offer highly reliable and competitively priced genomic testing solutions to institutional customers as well as to the Direct-to-Consumer market.
Genomic investigators at life science companies, contract research organizations, academic institutions and public-sector research facilities now have access to the company’s Genomics Research Center, a CLIA registered lab, which has processed more than 5 million discrete DNA tests for more than 700,000 individuals and organizations since it was established 12 years ago.
Gene By Gene Earns AABB Accreditation
Houston, TX – November 12, 2009 – Family Tree DNA announced today that it has been granted AABB
accreditation for Relationship Tests.
Accreditation followed an intensive on-site assessment by specially trained AABB assessors which
established that the level of technical and administrative performance within the facility meets or exceeds
the standards set by AABB. By successfully meeting those requirements, Family Tree DNA becomes part
of a select group of facilities located throughout the United States and the world which have earned AABB
Who Do You Think You Are? Live!
Family Tree DNA is the official sponsor of the DNA section of Who Do You Think You Are? Live! Order your test as seen on TV.
Family Finder uses autosomal DNA (inherited from both the mother and father, four grandparents, eight great-grandparents, etc.) to provide you a breakdown of your ethnic percentages and connect you with relatives descended from any of your ancestral lines within approximately the last 5 generations.
genetic matches with relationship ranges, visual tools to show matching DNA, and ethnic percentages. Family Tree DNA does not charge a subscription fee. We will continue to update you about new matches and other information regarding your results
Family Finder Test Confirms NFL Players are half-siblings...
In a few days, the NFL will make its final purge, casting away pieces that don't fit. Xavier Omon, a fourth-string running back for the San Francisco 49ers, might be on one of those lists, and it won't be a stunning revelation for a man who has been cut three times. In life, like in football, Omon has struggled to fit in. He was one of just three African-American kids at Beatrice High School in southeastern Nebraska, and freshman year, he says he was called the N-word. "Honestly," he said, "I beat the hell out of the kid. It never happened again." He lost two brothers by the time he was 15 and never knew his biological father.
But Omon used to dream about what his dad was like. He'd be big and strong and look just like him, but with a beard and an older face. He'd buy him a Game Boy and take him places. The old man called once, when Xavier was in fourth or fifth grade, and promised to visit. Omon says he never heard from him again.
So for nearly 26 years, Xavier Omon felt as if he had half of a life. Then a message came that changed everything.